Prognostic value and relapse pattern of HER2 ‐low in hormone receptor‐positive breast cancer

ConclusionsNo significant difference in DFS and OS between the HER2-low group and the HER2-zero group was observed. Patients with HER2 IHC 1+ and 0 tend to develop bone metastasis. The HER2-low group had a more obvious second peak in mortality.

https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.15221?af=R

Source: Thoracic Cancer - January 26, 2024 Category: Cancer & Oncology Authors: Tong Wei, Yikun Kang, Xue Wang, Jian Yue, Binghe Xu, Peng Yuan Tags: ORIGINAL ARTICLE Source Type: research